Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Orphan Lung Diseases Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Orphan Lung Diseases Treatmentmarket, defines the market attractiveness level of Orphan Lung Diseases Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Orphan Lung Diseases Treatment industry, describes the types of Orphan Lung Diseases Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orphan Lung Diseases Treatment market and the development prospects and opportunities of Orphan Lung Diseases Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orphan Lung Diseases Treatment market in Chapter 13.
By Player:
Sanofi
Pfizer
Synageva BioPharma
Auspex Pharmaceuticals
Novartis
Celgene
NPS Pharmaceuticals
Roche
GSK
By Type:
Immunosuppressants
Anti-Inflammatory Drugs
Anti-Fibrotic Agents
Vasodilators
Corticosteroids
CFTR Modulators
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Orphan Lung Diseases Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Orphan Lung Diseases Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Orphan Lung Diseases Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Orphan Lung Diseases Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Orphan Lung Diseases Treatment Market Analysis and Outlook to 2022
-
7.1 Global Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.2 United States Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.3 Europe Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.4 China Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.5 Japan Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.6 India Orphan Lung Diseases Treatment Consumption (2017-2022)
-
7.7 South Korea Orphan Lung Diseases Treatment Consumption (2017-2022)
8 Region and Country-wise Orphan Lung Diseases Treatment Market Analysis and Outlook to 2028
-
8.1 Global Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.2 United States Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.4 China Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.6 India Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Orphan Lung Diseases Treatment Consumption Forecast (2022-2028)
9 Global Orphan Lung Diseases Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Orphan Lung Diseases Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunosuppressants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-Fibrotic Agents Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Vasodilators Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.6 Global CFTR Modulators Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Orphan Lung Diseases Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Orphan Lung Diseases Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunosuppressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-Fibrotic Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global CFTR Modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Orphan Lung Diseases Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Orphan Lung Diseases Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Orphan Lung Diseases Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Orphan Lung Diseases Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Orphan Lung Diseases Treatment Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Orphan Lung Diseases Treatment Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Orphan Lung Diseases Treatment Product and Service
-
14.3 Synageva BioPharma
-
14.3.1 Synageva BioPharma Company Details
-
14.3.2 Synageva BioPharma Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Synageva BioPharma Orphan Lung Diseases Treatment Product and Service
-
14.4 Auspex Pharmaceuticals
-
14.4.1 Auspex Pharmaceuticals Company Details
-
14.4.2 Auspex Pharmaceuticals Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Auspex Pharmaceuticals Orphan Lung Diseases Treatment Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Orphan Lung Diseases Treatment Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Orphan Lung Diseases Treatment Product and Service
-
14.7 NPS Pharmaceuticals
-
14.7.1 NPS Pharmaceuticals Company Details
-
14.7.2 NPS Pharmaceuticals Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 NPS Pharmaceuticals Orphan Lung Diseases Treatment Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Orphan Lung Diseases Treatment Product and Service
-
14.9 GSK
-
14.9.1 GSK Company Details
-
14.9.2 GSK Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GSK Orphan Lung Diseases Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Orphan Lung Diseases Treatment
-
Figure Orphan Lung Diseases Treatment Picture
-
Table Global Orphan Lung Diseases Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Orphan Lung Diseases Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Orphan Lung Diseases Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Orphan Lung Diseases Treatment Consumption by Country (2017-2022)
-
Figure United States Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Orphan Lung Diseases Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Orphan Lung Diseases Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Orphan Lung Diseases Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppressants Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Fibrotic Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global CFTR Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Fibrotic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CFTR Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Orphan Lung Diseases Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Orphan Lung Diseases Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Orphan Lung Diseases Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Orphan Lung Diseases Treatment Product and Service
-
Table Synageva BioPharma (Foundation Year, Company Profile and etc.)
-
Table Synageva BioPharma Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synageva BioPharma Orphan Lung Diseases Treatment Product and Service
-
Table Auspex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Auspex Pharmaceuticals Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Auspex Pharmaceuticals Orphan Lung Diseases Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Orphan Lung Diseases Treatment Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Orphan Lung Diseases Treatment Product and Service
-
Table NPS Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table NPS Pharmaceuticals Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table NPS Pharmaceuticals Orphan Lung Diseases Treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Orphan Lung Diseases Treatment Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Orphan Lung Diseases Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Orphan Lung Diseases Treatment Product and Service
-
